Forbes Includes Acadia, Maker of Nuplazid on List of Most Innovative Growth Companies

Share

(July 27, 2017) - Acadia Pharmaceuticals, the maker of Nuplazid (pimavanserin), an oral medication to treat hallucinations and delusions associated with Parkinson’s disease (PD), was ranked 11th on Forbes Magazine’s 2017 list of the “World’s Most Innovative Growth Companies.” Read more

Click for a printer friendly version

Back to top